Compare Guardant Health Inc. Common Stock (GH) vs W W Grainger Inc (GWW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Guardant Health Inc. Common Stock vs W W Grainger Inc — how do they compare? Guardant Health Inc. Common Stock trades at $167.06 (market cap $22.22B), while W W Grainger Inc trades at $1,289.74 (market cap $59.76B). The key difference: W W Grainger Inc is far larger — about 2.7× Guardant Health Inc. Common Stock's market cap, and W W Grainger Inc pays a 0.79% dividend while Guardant Health Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 1 Days and W W Grainger Inc for 25 Days on average.
| GH | GWW | |
|---|---|---|
Market Cap | $22.22B | $59.76B |
Volume | 1,589,453 | 186,697 |
Sector | Health | Industrials |
52-Week High | $187.22 | $1.40K |
52-Week Low | $61.73 | $918.18 |
Typical Hold Time | 1 Days | 25 Days |
Enterprise Value | $22.86B | $61.96B |
Dividend Yield | — | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
W.W. Grainger (GWW) trades at $1,263.51, down 0.94% on the day, amid a bearish technical signal. Recent earnings show mixed results with Q4 2025 missing estimates but Q1 and Q2 2026 beating expectations. The company maintains strong profitability with a net income margin of 9.92% and ROE of 47.92%, though valuation ratios like P/E of 32.34 appear elevated. Recent news highlights institutional buying and expansion efforts, including a new distribution center in Oregon and the acquisition of technology assets from Adroit Worldwide Media.
The outlook for GWW is cautiously optimistic, supported by earnings beats and solid fundamentals, but risks include high valuation and competitive pressures. Analyst consensus leans hold with a $1,310 price target, suggesting limited upside. Investors should weigh strong cash flow and dividend consistency against potential margin compression and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Guardant Health Inc. Common Stock
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →About W W Grainger Inc
Grainger is a leading broad-line distributor of maintenance, repair, and operating (MRO) products. It serves millions of customers worldwide through an integrated network of branches and digital platforms.
Read more on GWW →
